Pure erythroid leukemia
- PMID: 33235778
- PMCID: PMC7669395
- DOI: 10.1002/ccr3.3056
Pure erythroid leukemia
Abstract
The diagnosis of pure erythroid leukemia (PEL) can be challenging. Prompt identification of CD45+, CD34-, CD71+, CD117+, and E-cadherin+ erythroblasts is important. The differential diagnosis is broad and includes megaloblastic anemia.
Keywords: complex karyotype; erythroblast; erythroid leukemia; myeloid leukemia; tp53 mutation.
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Conflict of interest statement
None declared.
Figures




References
-
- Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391‐2405. - PubMed
-
- Reinig EF, Greipp PT, Chiu A, Howard MT, Reichard KK. De novo pure erythroid leukemia: refining the clinicopathologic and cytogenetic characteristics of a rare entity. Modern Pathol. 2018;31(5):705‐717. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous